科研之友
微信
新浪微博
Facebook
分享链接
摘要
Many kidney diseases are associated with inflammation and altered immune response. Mesenchymal stem cells (MSCs) are known for their anti-inflammatory properties and immune modulation. Demonstration that the phenotype and immunosuppressive ability of adipose tissue-derived MSCs are not affected by human kidney disease or uremic serum might have clinical significance if autologous adipose tissue-derived MSCs can be tested to prove their long-term safety and efficacy in treating kidney disease. Kidney International (2012) 82, 731-733. doi:10.1038/ki.2012.158
- 出版日期2012-10
